BioCryst Pharma (BCRX) PT Raised to $9 at RBC Capital

August 4, 2023 6:25 AM EDT Send to a Friend

RBC Capital analyst Brian Abraham ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

BioCryst Pharma (BCRX) PT Raised to $9 at RBC Capital

Member Login

Free News Feed